Global Male Infertility Market To Reach $4.66 Billion By 2029 With A Growth Rate Of 5.3%

June 18, 2025 10:35 AM BST | By EIN Presswire
 Global Male Infertility Market To Reach $4.66 Billion By 2029 With A Growth Rate Of 5.3%
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire.com/ -- The male infertility market size has experienced robust growth and is projected to escalate from $3.59 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate CAGR of 5.6%. Factors such as the rising awareness of male reproductive health, increasing prevalence of lifestyle-related disorders, growing adoption of assisted reproductive technologies ART, expansion of fertility clinics and diagnostic centers, and advancements in semen analysis technologies have driven this growth in the historical period.

What Is The Projected Future Growth Of The Male Infertility Market Size?
Anticipated to witness steady growth, the male infertility market size is projected to reach a market worth of $4.66 billion in 2029, driven by a CAGR of 5.3%. Can recent trends and an increase in genetic focus drive the forecast growth? Increasing focus on genetic and epigenetic factors, rising demand for personalized infertility treatments, growth in medical tourism for fertility care, technological innovations in sperm retrieval and preservation, and the emerging role of telehealth in fertility consultations are anticipated to circle the growth during the forecast period. Future trends include the increasing use of genetic testing for infertility diagnosis, advancements in sperm retrieval techniques like micro-TESE, growing demand for non-invasive fertility treatments, introduction of personalized male fertility treatment plans, and rising use of stem cell therapy for spermatogenesis restoration.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=24286&type=smp

What Are The Key Drivers Propelling The Growth Of The Male Infertility Market?
A curious market driver is the escalating stress levels, which are expected to propel the growth of the male infertility market going forward. But what is the cause behind rising stress levels and their impact on infertility in men? Stress levels refer to the intensity of emotional, physical, or mental strain experienced in response to challenging situations or pressures. The rising stress levels stem from escalating work demands, where relentless pressure and high expectations cause burnout and disrupt mental health and work-life balance. Elevated stress levels can interfere with hormone balance, decrease sperm quality, and impair sexual function, leading to male infertility. Chronic stress disrupts cortisol and testosterone levels, contributing to a rise in infertility cases. For instance, in May 2024, the American Psychiatric Association reported that 43% of adults in the US felt more anxious in 2024, compared to 37% in 2023 and 32% in 2022, highlighting a consistent increase in anxiety levels.

Who Are The Key Driving Forces In The Male Infertility Market?
Major companies on the male infertility market scene include Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, and Shree IVF Clinics

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

What Are The Emerging Trends In The Male Infertility Market?
A fascinating emerging trend in the male infertility market is the strategic partnership approach employed by major companies. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, partnered with Posterity Health, a US-based male fertility clinic, on a project to educate men about their fertility through the Fertility Out Loud platform. This initiative offers confidential online assessments and educational resources developed by reproductive urologists to reduce the stigma around male infertility, which contributes to up to 50% of infertility cases.

How Is The Male Infertility Market Segmented?
As for market segmentation, the male infertility market covered in the report is divided based on:
1 Treatment Type: Medication, Surgery, Assisted Reproductive Technology
2 Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types
3 Distribution Channel: Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies
4 End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users

Within these segments, the medications include hormone treatments, gonadotropins, antibiotics, antiestrogens, dopamine agonists. The surgical treatments range from varicocelectomy, vasovasostomy, epididymovasostomy, transurethral resection of the ejaculatory duct TURED, to sperm retrieval procedures. Assisted Reproductive Technology ART encompasses in vitro fertilization IVF, intracytoplasmic sperm injection ICSI, intrauterine insemination IUI, sperm donation, and cryopreservation of sperm.

What Are The Regional Insights In The Male Infertility Market?
In the regional landscape, North America was the largest region in the male infertility market in 2024. The regions covered in this report extend to Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:
Infertility Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Male Hypogonadism Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Male Toiletries Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/male-toiletries-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next